CRO 질량분석 서비스 시장 규모, 점유율 및 성장 분석 : 서비스 유형별, 장비 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cro Mass Spectroscopy Services Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 7.52 Billion by 2033, growing at a CAGR of 8.82% during the forecast period (2026-2033).

The global CRO mass spectrometry services market is primarily driven by the increasing demand for high-resolution and high-throughput analytical solutions from pharmaceutical and biotechnology firms. These organizations rely on contract research organizations for specialized mass spectrometry services that encompass ADME, toxicology testing, pharmacokinetics, and biomarker analysis. The high costs associated with replicating advanced equipment and expertise further bolster this market, which has evolved over time from simple small molecule analysis to complex techniques such as proteoform analysis and imaging mass spectrometry. Additionally, as sponsors seek to develop advanced biologics and drugs, the provision of comprehensive, end-to-end analytical workflows by CROs is fostering significant growth through increased project outsourcing by pharmaceutical companies, enhancing overall market revenues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cro Mass Spectroscopy Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cro Mass Spectroscopy Services Market Segments Analysis

Global CRO mass spectroscopy services market is segmented by service type, instrument type, application, end-user and region. Based on service type, the market is segmented into Metabolomics, Proteomics, Drug Metabolism & Pharmacokinetics (DMPK), Lipidomics and Others. Based on instrument type, the market is segmented into Quadrupole MS, TOF (Time-of-Flight), Orbitrap and Triple Quadrupole. Based on application, the market is segmented into Drug Discovery, Biomarker Discovery and Clinical Research. Based on end-user, the market is segmented into Pharma Companies, Biotech Companies and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cro Mass Spectroscopy Services Market

One of the key market drivers for the global CRO mass spectroscopy services market is the increasing demand for advanced analytical techniques in pharmaceutical and biotechnology sectors. As these industries continue to innovate and develop complex molecules, there is a growing need for precise and reliable characterizations of compounds to ensure efficacy and safety. Furthermore, the rising trend of outsourcing analytical services to contract research organizations (CROs) allows companies to focus on core activities while accessing cutting-edge technologies and expert knowledge, thereby fueling the growth of mass spectroscopy services. This shift towards specialization enhances operational efficiencies and accelerates drug development timelines.

Restraints in the Global Cro Mass Spectroscopy Services Market

One of the key market restraints for the global CRO mass spectroscopy services market is the high cost associated with advanced mass spectroscopy technologies and services. The significant investment required for sophisticated equipment, ongoing maintenance, and skilled personnel can deter smaller companies and research institutions from utilizing these services. Additionally, the complexity of mass spectroscopy methods may necessitate extensive training for staff, further driving up costs. As a result, budget constraints may limit access for potential clients in various sectors, including pharmaceuticals, environmental testing, and food safety, ultimately hindering market growth and innovation in mass spectroscopy services.

Market Trends of the Global Cro Mass Spectroscopy Services Market

The Global CRO Mass Spectroscopy Services market is witnessing a significant trend towards the adoption of integrated multiomics approaches. Clients increasingly seek comprehensive solutions that combine various omic fields, such as proteomics and metabolomics, along with sophisticated sample preparations and robust bioinformatics analyses. This rising demand encourages Contract Research Organizations (CROs) to diversify their service offerings and foster collaborations to enhance their technical capabilities. In response to this trend, CROs are focusing on providing bespoke assay development, stringent quality control measures, and detailed reporting services aimed at supporting both discovery and translational research, ultimately advancing scientific innovation and insights.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global CRO Mass Spectroscopy Services Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Metabolomics
• Proteomics
• Drug Metabolism & Pharmacokinetics (DMPK)
• Lipidomics
• Others

Global CRO Mass Spectroscopy Services Market Size by Instrument Type & CAGR (2026-2033)

• Market Overview
• Quadrupole MS
• TOF (Time-of-Flight)
• Orbitrap
• Triple Quadrupole

Global CRO Mass Spectroscopy Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Biomarker Discovery
• Clinical Research

Global CRO Mass Spectroscopy Services Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharma Companies
• Biotech Companies
• Research Institutes

Global CRO Mass Spectroscopy Services Market Size & CAGR (2026-2033)

• North America (Service Type, Instrument Type, Application, End-User)
  • US
  • Canada
• Europe (Service Type, Instrument Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Instrument Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Instrument Type, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Instrument Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (PPD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance (Labcorp Drug Development)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pace Analytical (GEL Laboratories)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioPharma Finder
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific BioLabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Q2 Solutions (IQVIA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Bioresearch
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations